EAB has completed successful community-based, randomized outcome studies on fibromyalgia (FM), chronic fatigue (CFIDS), and Type 1 & 2 diabetes, proving the validity and reliability of the LRA program.
"A Novel Treatment for Fibromyalgia Improves Clinical Outcomes in a Community-Based Study" read more
50% less pain
70% less depression
50% more energy
30% less stiffness
"Tolerance loss in diabetics: Link with foreign antigen exposure." read more
>1 mg/dl decrease in Hgb A1c levels in both Type 2 & Type 1 diabetes
18% reduction of insulin levels in Type 2 diabetes
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Important COVID-19 News: Reduce risk, boost immune system, and stay healthy.